Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 17:8:403.
doi: 10.3332/ecancer.2014.403. eCollection 2014.

Management of borderline ovarian tumours: a comprehensive review of the literature

Alejandra Abascal-Saiz  1 , Laura Sotillo-Mallo  1 , Javier de Santiago  1 , Ignacio Zapardiel  1
Affiliations
Review

Management of borderline ovarian tumours: a comprehensive review of the literature

Alejandra Abascal-Saiz et al. Ecancermedicalscience. .

Abstract

Borderline ovarian tumours differ from epithelial ovarian cancer by their low incidence, frequent association with infertility, low association with mutations in BCRA genes, different percentages of the most common histological types, early stage diagnosis, and high survival rate, even when associated with peritoneal involvement. They occur in younger women, which is why one of the objectives in these patients will be the preservation of fertility. The management of these tumours has been widely discussed and still continues to be controversial. The latest findings underscore the importance of full staging in both radical and conservative surgery, to choose the most comprehensive treatment and obtain an accurate prognosis. One of the objectives of this article shall be the in-depth review of the indications, benefits, and disadvantages of each type of surgery, as well as the usefulness of the medical treatment. In addition, the article aims to review follow-up guidelines and to clarify the main prognostic factors that affect recurrence and survival of these patients.

Keywords: borderline ovarian tumour; fertility-sparing surgery; management.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Ovarian tumour classification (WHO).
See this image and copyright information in PMC

References

    1. Göran Tropé C, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26:325–36. doi: 10.1016/j.bpobgyn.2011.12.006. - DOI - PubMed
    1. Morice P, et al. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012;13(3):e103–15. doi: 10.1016/S1470-2045(11)70288-1. DOI: 10.1016/S1470-2045(11)70288-1. - DOI - PubMed
    1. Fischerova D, et al. Diagnosis, treatment, and follow-up of borderline ovarian tumors. Oncologist. 2012;17:1515–33. doi: 10.1634/theoncologist.2012-0139. - DOI - PMC - PubMed
    1. Yokoyama Y, et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumors. Br J Cancer. 2006;94:1586–91. - PMC - PubMed
    1. Ray-Coquard I, et al. Tumores infrecuentes del ovario: estrategias terapéuticas y organización del tratamiento. EMC-Ginecología-Obstetricia. 2012;48(1):1–10. doi: 10.1016/S1283-081X(12)60834-0. [Article 680-A-50] - DOI